Within the group of women with silicone implants and CTD (Group 1), between those women with paraproteins and those women without paraproteins there were only borderline significant differences or no significant differences (Mann–Whitney U test) in age (55.6 years versus 49.3 years, P = 0.041), in duration of CTD (10.4 versus 6.4 years, P = 0.051), in implant duration (10.2 years versus 12.5 years, P = 0.267), and in duration of silicone exposure (16.1 years versus 15.4 years, P = 0.783).
Excerpts
The monitoring rate increased significantly for succinylcholine in two departments post‐intervention ( p = .045 and .010), and for non‐depolarising relaxants in one department ( p = .041), but followed by a negative trend of −37.0% per year ( p = .041).
The power within each spectral band did not statistically differ among the nine intervals based on Friedman tests for the VLF band (p=0.358) or the LF band (p=0.081) but was marginally significant for the HF band (p=0.041).
After 3 years' median follow-up, the PFS difference between atezolizumab and placebo did not reach statistical significance in the ITT (hazard ratio [HR], 0.83; 95% CI, 0.69 to 0.99; P = .041; median 13.5 v 11.3 months, respectively) or PD-L1–positive (HR, 0.86; 95% CI, 0.63 to 1.16; P = .30; median 15.2 v 13.1 months, respectively) populations.
The prespecified MCI group (MMSE >26, N = 125) showed nominally significant positive effects on ADAS-Cog13 (52%, nominal p = 0.041) and DAD (96%, nominal p = 0.016), positive trend on CDR-SB (102%, nominal p = 0.053), with significant hippocampal atrophy slowing (26%, p = 0.004), and positive grey/white matter effects on MRI-DTI.
Player hours in previous season is marginally significant (p=0.041).
Although the investigated polymorphisms were not related to demographic features, clinicopathological lung tumour characteristics, or blood morphology indices, marginally significant correlations were found with some variables: C1236T with age of disease onset ( p =0.0410); C3435T with smoking status ( p =0.0561).
An increasing trend was observed among men who had at least two positive lifestyle changes across the study period ( p = 0.041) (Table 1 ).
We determined highly significant differences among the anastomotic sites with regard to day-1 urea level (p = 0.041), day-1 creatinine level (p = 0.002), day-7 urea level (p = 0.017) and day-7 creatinine level (p = 0.001) (Table 3).
We found slightly significant publication bias in 34 studies ( P = .041).
In the observation group, we found favorable prognostic effects of low MUC1 expression (HR for DFS: 0.55; 95% CI 0.29 to 1.04, p = .062; HR for OS: 0.35, 95% CI 0.18 to 0.68, p = .001) as well as a strong trend for improved survival in the gemcitabine group (HR for DFS: 0.48; 95% CI 0.24 to 0.96, p = .041; HR for OS: 0.56, 95% CI 0.28 to 1.11, p = .093), see Figures 3E–H : Survival analyses in subgroups for gemcitabine vs. observation.
failed to reach significancep = 0.041
Changes in JOA and SF-36 failed to reach significance between two groups, while preoperative NDI in the high SCA category was larger than the low SCA category (23.33 ± 5.70 vs 19.32 ± 4.92, p = 0.041). △NDI (pre vs post) and △NDI (pre vs F/U) in the high SCA group exceeded than that in the low SCA group (pre vs post: p = 0.018, pre vs F/U: p = 0.048) (Table 3 ).
In the TKI-treated cohort (n=118), the subtypes showed a clear trend towards prognostic stratification (log-rank p-value =0.041; Figure 5E ).
showed a trendP = 0.041
Results A univariate analysis showed that CD133 expression in male patients at the late stage (II and III) was significantly associated with worse progression-free survival (PFS) ( P = 0.0057) and overall survival (OS) ( P = 0.015), and a multivariate analysis showed a trend toward worse OS ( P = 0.041).
The Pearson correlation analysis showed marginally significant ( p = 0.041–0.076) moderate correlations between the working time values determined using ISO 4049 and FTIR (Fig. 4 ).
EP (group 2) following DNA vaccination, although this did not reach statistical significance, except for TNF-α responses that were greater than those in group 1 (group 3; p = 0.041, chop-lump test).
Comparison of GM_n across different DWMH Fazekas scores Kruskal–Wallis testing revealed a marginally significant group-level difference in GM_n across DWMH Fazekas scores ( p = 0.041).
Invasive and non-invasive cBPsys linear regression analysis with the FF catheter showed a positive trend when BP increased ( p = 0.041), indicating an underestimation of the Uscom BP+ device as cBPsys increased, while cBPdia and cBPmean were found to be unaffected.
When stratified analysis was carried out in the group aged 8–10 years old, the children in 2015–2017 reported significantly lower summed scores on items belonging to factor III compared with peers in 2008–2011, while no significant differences were seen in items for the other three factors, indicating a decreasing trend in anxiety levels over time for the ‘less invasive procedures’ items (factor III) ( table 5 , p=0.041).
According to Pillai's Trace multivariate effects were highly significant for the FTND F (7, 156) = 2.107, p < 0.041, partial η2 = 0.086.
In the relative log(biomass) model (also R 2 = 0.10), the interaction between seed mass and the squared term for heterospecific density was marginally significant ( P = 0.041, Table 4 ) and indicated that light-seeded species exhibited a shallow hump-shaped relationship with heterospecific density whereas heavy-seeded species exhibited a shallow U-shaped relationship (Fig.
In addition, the rate of cancer-bearing offspring was higher in the InterVar P or LP carriers than in the others with marginally significant (p = 0.041).
In addition, the estimates of GP17 on T2D were marginally statistically significant in size in the weighted median method (OR = 0.671, 95% CI = 0.458–0.984, P = 0.041) but not in the IVW method and MR‒Egger method.
The baked clay and the painted cement surfaces did provide slightly significant differences in mortality ( p = 0.041).
approached significanceP < 0.041
None of the other effects approached significance (all F s < 2.13, P s > 0.15, η 2 P < 0.041, η 2 G < 0.009).